Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Merck Serono Plans Lab In China

September 19, 2011 | A version of this story appeared in Volume 89, Issue 38

Merck Serono is setting up its China R&D lab within the site of Pharmaron’s new campus at the Beijing Economic & Technological Development Area. The new lab will focus on clinical bioanalysis and biomarker characterization in a Chinese population. It will support Merck Serono’s efforts in the area of personalized medicine for cancer and neurodegenerative diseases. Pharmaron is among China’s five largest pharmaceutical contract research organizations.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.